P

Inventor

MULLER GEORGE W

US164 patents
⚠️ This page may combine multiple inventors who share the name “MULLER GEORGE W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE CORP

46 patents
US7465800B2Dec 16, 2008

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

CELGENE CORP87 citations99
US7244759B2Jul 17, 2007

Isoindoline compounds and methods of making and using the same

CELGENE CORP138 citations99
US7091353B2Aug 15, 2006

Isoindole-imide compounds, compositions, and uses thereof

CELGENE CORP147 citations99
US6962940B2Nov 8, 2005

(+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof

CELGENE CORP107 citations99
US6555554B2Apr 29, 2003

Isoindolines, method of use, and pharmaceutical compositions

CELGENE CORP245 citations99
US6476052B1Nov 5, 2002

Isoindolines, method of use, and pharmaceutical compositions

CELGENE CORP295 citations99
US6395754B1May 28, 2002

Substituted 2-(2,6-dioxopiperidin-3-yl)- phthalimides and 1-oxoisoindolines and method of reducing TNFα levels

CELGENE CORP296 citations99
US6335349B1Jan 1, 2002

Substituted 2(2,6-dioxopiperidin-3-yl)isoindolines

CELGENE CORP301 citations99
US6316471B1Nov 13, 2001

Isoindolines, method of use, and pharmaceutical compositions

CELGENE CORP334 citations99
US6281230B1Aug 28, 2001

Isoindolines, method of use, and pharmaceutical compositions

CELGENE CORP400 citations99
US6046221AApr 4, 2000

Immunotherapeutic aryl amides

CELGENE CORP108 citations99
US6020358AFeb 1, 2000

Substituted phenethylsulfones and method of reducing TNFα levels

CELGENE CORP296 citations99
US6011050AJan 4, 2000

Substituted phenethylsulfones and method of reducing TNFα levels

CELGENE CORP172 citations99
US5955476ASep 21, 1999

Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels

CELGENE CORP267 citations99
US5929117AJul 27, 1999

Immunotherapeutic agents

CELGENE CORP319 citations99
US5877200AMar 2, 1999

Cyclic amides

CELGENE CORP351 citations99
US5874448AFeb 23, 1999

Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels

CELGENE CORP285 citations99
US5801195ASep 1, 1998

Immunotherapeutic aryl amides

CELGENE CORP121 citations99
US5798368AAug 25, 1998

Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines and method of reducing TNFα levels

CELGENE CORP305 citations99
US5736570AApr 7, 1998

Immunotherapeutic aryl amides

CELGENE CORP114 citations99
US5728845AMar 17, 1998

Immunotherapeutic nitriles

CELGENE CORP122 citations99
US5728844AMar 17, 1998

Immunotherapeutic agents

CELGENE CORP171 citations99
US5698579ADec 16, 1997

Cyclic amides

CELGENE CORP345 citations99
US5605914AFeb 25, 1997

Imides

CELGENE CORP152 citations99
US7893101B2Feb 22, 2011

Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof

CELGENE CORP44 citations98
US7635700B2Dec 22, 2009

5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same

CELGENE CORP78 citations98
US6667316B1Dec 23, 2003

Pharmaceutically active isoindoline derivatives

CELGENE CORP88 citations98
US6326388B1Dec 4, 2001

Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level

CELGENE CORP115 citations98
US5703098ADec 30, 1997

Immunotherapeutic imides/amides

CELGENE CORP113 citations98
US5658940AAug 19, 1997

Succinimide and maleimide cytokine inhibitors

CELGENE CORP138 citations98
US7427638B2Sep 23, 2008

(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione:, and methods of synthesis and compositions thereof

CELGENE CORP53 citations97
US6380239B1Apr 30, 2002

Substituted 1-oxo- and 1,3-dioxoisoindoline and method of reducing inflammatory cytokine levels

CELGENE CORP253 citations97
US5635517AJun 3, 1997

Method of reducing TNFα levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines

CELGENE CORP643 citations97
US7855217B2Dec 21, 2010

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

CELGENE CORP42 citations96
US7659303B2Feb 9, 2010

Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4- acetylaminoisoindoline-1,3-dione

CELGENE CORP21 citations96
US7659302B2Feb 9, 2010

Methods of using (+)-2-[1-(3-ethoxy-4 methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione

CELGENE CORP35 citations96
US7507759B2Mar 24, 2009

Methods of using(+)-2-[1-(3-ethoxy-4methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3,-dione

CELGENE CORP21 citations96
US7358272B2Apr 15, 2008

Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione

CELGENE CORP21 citations96
US7119106B2Oct 10, 2006

Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline

CELGENE CORP53 citations96
US7041680B2May 9, 2006

(R) and (S) isomers of substituted 2-(2,6-dioxopiperidin-3-yl) phthalimides and 1-oxoisoindolines and methods of using the same

CELGENE CORP38 citations96
US6911464B2Jun 28, 2005

N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses

CELGENE CORP41 citations96
US6262101B1Jul 17, 2001

Immunotherapeutic agents

CELGENE CORP41 citations96
US6214857B1Apr 10, 2001

Substituted alkanohydroxamic acids and method of reducing TNFα levels

CELGENE CORP76 citations96
US6200987B1Mar 13, 2001

Cyclic amides

CELGENE CORP52 citations96
US6180644B1Jan 30, 2001

Immunotherapeutic agents

CELGENE CORP47 citations96
US6130226AOct 10, 2000

Immunotherapeutic agents

CELGENE CORP55 citations96

MULLER GEORGE W

2 patents

(unassigned)

1 patent

MAN HON-WAH

1 patent

Showing the top 50 of 164 patents by PatentIndex Score.